- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The In-Silico Drug Discovery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global In-Silico Drug Discovery market size is estimated to be worth US$ 2048.6 million in 2021 and is forecast to a readjusted size of USD 4358.6 million by 2028 with a CAGR of 11.4% during review period. Contract Research Organization accounting for % of the In-Silico Drug Discovery global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Software as a Service (Cloud) segment is altered to a % CAGR between 2022 and 2028.
Global key companies of In-Silico Drug Discovery include Charles River, Certara USA, Inc., Evotec, Dassault System (Biovia), and Albany Molecular Research Inc. (AMRI), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
In-Silico Drug Discovery market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Software as a Service (Cloud)
Consultancy as a Service
Software
Market segment by Application, can be divided into
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
Market segment by players, this report covers
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schrödinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe In-Silico Drug Discovery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of In-Silico Drug Discovery, with revenue, gross margin and global market share of In-Silico Drug Discovery from 2019 to 2022.
Chapter 3, the In-Silico Drug Discovery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and In-Silico Drug Discovery market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe In-Silico Drug Discovery research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of In-Silico Drug Discovery
1.2 Classification of In-Silico Drug Discovery by Type
1.2.1 Overview: Global In-Silico Drug Discovery Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global In-Silico Drug Discovery Revenue Market Share by Type in 2021
1.2.3 Software as a Service (Cloud)
1.2.4 Consultancy as a Service
1.2.5 Software
1.3 Global In-Silico Drug Discovery Market by Application
1.3.1 Overview: Global In-Silico Drug Discovery Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Contract Research Organization
1.3.3 Pharmaceutical Industry
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Global In-Silico Drug Discovery Market Size & Forecast
1.5 Global In-Silico Drug Discovery Market Size and Forecast by Region
1.5.1 Global In-Silico Drug Discovery Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global In-Silico Drug Discovery Market Size by Region, (2017-2022)
1.5.3 North America In-Silico Drug Discovery Market Size and Prospect (2017-2028)
1.5.4 Europe In-Silico Drug Discovery Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific In-Silico Drug Discovery Market Size and Prospect (2017-2028)
1.5.6 South America In-Silico Drug Discovery Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa In-Silico Drug Discovery Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 In-Silico Drug Discovery Market Drivers
1.6.2 In-Silico Drug Discovery Market Restraints
1.6.3 In-Silico Drug Discovery Trends Analysis
2 Company Profiles
2.1 Charles River
2.1.1 Charles River Details
2.1.2 Charles River Major Business
2.1.3 Charles River In-Silico Drug Discovery Product and Solutions
2.1.4 Charles River In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Charles River Recent Developments and Future Plans
2.2 Certara USA, Inc.
2.2.1 Certara USA, Inc. Details
2.2.2 Certara USA, Inc. Major Business
2.2.3 Certara USA, Inc. In-Silico Drug Discovery Product and Solutions
2.2.4 Certara USA, Inc. In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Certara USA, Inc. Recent Developments and Future Plans
2.3 Evotec
2.3.1 Evotec Details
2.3.2 Evotec Major Business
2.3.3 Evotec In-Silico Drug Discovery Product and Solutions
2.3.4 Evotec In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Evotec Recent Developments and Future Plans
2.4 Dassault System (Biovia)
2.4.1 Dassault System (Biovia) Details
2.4.2 Dassault System (Biovia) Major Business
2.4.3 Dassault System (Biovia) In-Silico Drug Discovery Product and Solutions
2.4.4 Dassault System (Biovia) In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Dassault System (Biovia) Recent Developments and Future Plans
2.5 Albany Molecular Research Inc. (AMRI)
2.5.1 Albany Molecular Research Inc. (AMRI) Details
2.5.2 Albany Molecular Research Inc. (AMRI) Major Business
2.5.3 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Product and Solutions
2.5.4 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Albany Molecular Research Inc. (AMRI) Recent Developments and Future Plans
2.6 Selvita
2.6.1 Selvita Details
2.6.2 Selvita Major Business
2.6.3 Selvita In-Silico Drug Discovery Product and Solutions
2.6.4 Selvita In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Selvita Recent Developments and Future Plans
2.7 Schrödinger, Inc.
2.7.1 Schrödinger, Inc. Details
2.7.2 Schrödinger, Inc. Major Business
2.7.3 Schrödinger, Inc. In-Silico Drug Discovery Product and Solutions
2.7.4 Schrödinger, Inc. In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Schrödinger, Inc. Recent Developments and Future Plans
2.8 GVK BIO
2.8.1 GVK BIO Details
2.8.2 GVK BIO Major Business
2.8.3 GVK BIO In-Silico Drug Discovery Product and Solutions
2.8.4 GVK BIO In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 GVK BIO Recent Developments and Future Plans
2.9 OpenEye Scientific Software
2.9.1 OpenEye Scientific Software Details
2.9.2 OpenEye Scientific Software Major Business
2.9.3 OpenEye Scientific Software In-Silico Drug Discovery Product and Solutions
2.9.4 OpenEye Scientific Software In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 OpenEye Scientific Software Recent Developments and Future Plans
2.10 Chemical Computing Group (CCG)
2.10.1 Chemical Computing Group (CCG) Details
2.10.2 Chemical Computing Group (CCG) Major Business
2.10.3 Chemical Computing Group (CCG) In-Silico Drug Discovery Product and Solutions
2.10.4 Chemical Computing Group (CCG) In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Chemical Computing Group (CCG) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global In-Silico Drug Discovery Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 In-Silico Drug Discovery Players Market Share in 2021
3.2.2 Top 10 In-Silico Drug Discovery Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 In-Silico Drug Discovery Players Head Office, Products and Services Provided
3.4 In-Silico Drug Discovery Mergers & Acquisitions
3.5 In-Silico Drug Discovery New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global In-Silico Drug Discovery Revenue and Market Share by Type (2017-2022)
4.2 Global In-Silico Drug Discovery Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global In-Silico Drug Discovery Revenue Market Share by Application (2017-2022)
5.2 Global In-Silico Drug Discovery Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America In-Silico Drug Discovery Revenue by Type (2017-2028)
6.2 North America In-Silico Drug Discovery Revenue by Application (2017-2028)
6.3 North America In-Silico Drug Discovery Market Size by Country
6.3.1 North America In-Silico Drug Discovery Revenue by Country (2017-2028)
6.3.2 United States In-Silico Drug Discovery Market Size and Forecast (2017-2028)
6.3.3 Canada In-Silico Drug Discovery Market Size and Forecast (2017-2028)
6.3.4 Mexico In-Silico Drug Discovery Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe In-Silico Drug Discovery Revenue by Type (2017-2028)
7.2 Europe In-Silico Drug Discovery Revenue by Application (2017-2028)
7.3 Europe In-Silico Drug Discovery Market Size by Country
7.3.1 Europe In-Silico Drug Discovery Revenue by Country (2017-2028)
7.3.2 Germany In-Silico Drug Discovery Market Size and Forecast (2017-2028)
7.3.3 France In-Silico Drug Discovery Market Size and Forecast (2017-2028)
7.3.4 United Kingdom In-Silico Drug Discovery Market Size and Forecast (2017-2028)
7.3.5 Russia In-Silico Drug Discovery Market Size and Forecast (2017-2028)
7.3.6 Italy In-Silico Drug Discovery Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific In-Silico Drug Discovery Revenue by Type (2017-2028)
8.2 Asia-Pacific In-Silico Drug Discovery Revenue by Application (2017-2028)
8.3 Asia-Pacific In-Silico Drug Discovery Market Size by Region
8.3.1 Asia-Pacific In-Silico Drug Discovery Revenue by Region (2017-2028)
8.3.2 China In-Silico Drug Discovery Market Size and Forecast (2017-2028)
8.3.3 Japan In-Silico Drug Discovery Market Size and Forecast (2017-2028)
8.3.4 South Korea In-Silico Drug Discovery Market Size and Forecast (2017-2028)
8.3.5 India In-Silico Drug Discovery Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia In-Silico Drug Discovery Market Size and Forecast (2017-2028)
8.3.7 Australia In-Silico Drug Discovery Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America In-Silico Drug Discovery Revenue by Type (2017-2028)
9.2 South America In-Silico Drug Discovery Revenue by Application (2017-2028)
9.3 South America In-Silico Drug Discovery Market Size by Country
9.3.1 South America In-Silico Drug Discovery Revenue by Country (2017-2028)
9.3.2 Brazil In-Silico Drug Discovery Market Size and Forecast (2017-2028)
9.3.3 Argentina In-Silico Drug Discovery Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa In-Silico Drug Discovery Revenue by Type (2017-2028)
10.2 Middle East & Africa In-Silico Drug Discovery Revenue by Application (2017-2028)
10.3 Middle East & Africa In-Silico Drug Discovery Market Size by Country
10.3.1 Middle East & Africa In-Silico Drug Discovery Revenue by Country (2017-2028)
10.3.2 Turkey In-Silico Drug Discovery Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia In-Silico Drug Discovery Market Size and Forecast (2017-2028)
10.3.4 UAE In-Silico Drug Discovery Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global In-Silico Drug Discovery Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global In-Silico Drug Discovery Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market In-Silico Drug Discovery Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global In-Silico Drug Discovery Revenue (USD Million) by Region (2017-2022)
Table 5. Global In-Silico Drug Discovery Revenue Market Share by Region (2023-2028)
Table 6. Charles River Corporate Information, Head Office, and Major Competitors
Table 7. Charles River Major Business
Table 8. Charles River In-Silico Drug Discovery Product and Solutions
Table 9. Charles River In-Silico Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Certara USA, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Certara USA, Inc. Major Business
Table 12. Certara USA, Inc. In-Silico Drug Discovery Product and Solutions
Table 13. Certara USA, Inc. In-Silico Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Evotec Corporate Information, Head Office, and Major Competitors
Table 15. Evotec Major Business
Table 16. Evotec In-Silico Drug Discovery Product and Solutions
Table 17. Evotec In-Silico Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Dassault System (Biovia) Corporate Information, Head Office, and Major Competitors
Table 19. Dassault System (Biovia) Major Business
Table 20. Dassault System (Biovia) In-Silico Drug Discovery Product and Solutions
Table 21. Dassault System (Biovia) In-Silico Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Albany Molecular Research Inc. (AMRI) Corporate Information, Head Office, and Major Competitors
Table 23. Albany Molecular Research Inc. (AMRI) Major Business
Table 24. Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Product and Solutions
Table 25. Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Selvita Corporate Information, Head Office, and Major Competitors
Table 27. Selvita Major Business
Table 28. Selvita In-Silico Drug Discovery Product and Solutions
Table 29. Selvita In-Silico Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Schrödinger, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Schrödinger, Inc. Major Business
Table 32. Schrödinger, Inc. In-Silico Drug Discovery Product and Solutions
Table 33. Schrödinger, Inc. In-Silico Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. GVK BIO Corporate Information, Head Office, and Major Competitors
Table 35. GVK BIO Major Business
Table 36. GVK BIO In-Silico Drug Discovery Product and Solutions
Table 37. GVK BIO In-Silico Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. OpenEye Scientific Software Corporate Information, Head Office, and Major Competitors
Table 39. OpenEye Scientific Software Major Business
Table 40. OpenEye Scientific Software In-Silico Drug Discovery Product and Solutions
Table 41. OpenEye Scientific Software In-Silico Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Chemical Computing Group (CCG) Corporate Information, Head Office, and Major Competitors
Table 43. Chemical Computing Group (CCG) Major Business
Table 44. Chemical Computing Group (CCG) In-Silico Drug Discovery Product and Solutions
Table 45. Chemical Computing Group (CCG) In-Silico Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global In-Silico Drug Discovery Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global In-Silico Drug Discovery Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of In-Silico Drug Discovery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. In-Silico Drug Discovery Players Head Office, Products and Services Provided
Table 50. In-Silico Drug Discovery Mergers & Acquisitions in the Past Five Years
Table 51. In-Silico Drug Discovery New Entrants and Expansion Plans
Table 52. Global In-Silico Drug Discovery Revenue (USD Million) by Type (2017-2022)
Table 53. Global In-Silico Drug Discovery Revenue Share by Type (2017-2022)
Table 54. Global In-Silico Drug Discovery Revenue Forecast by Type (2023-2028)
Table 55. Global In-Silico Drug Discovery Revenue by Application (2017-2022)
Table 56. Global In-Silico Drug Discovery Revenue Forecast by Application (2023-2028)
Table 57. North America In-Silico Drug Discovery Revenue by Type (2017-2022) & (USD Million)
Table 58. North America In-Silico Drug Discovery Revenue by Type (2023-2028) & (USD Million)
Table 59. North America In-Silico Drug Discovery Revenue by Application (2017-2022) & (USD Million)
Table 60. North America In-Silico Drug Discovery Revenue by Application (2023-2028) & (USD Million)
Table 61. North America In-Silico Drug Discovery Revenue by Country (2017-2022) & (USD Million)
Table 62. North America In-Silico Drug Discovery Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe In-Silico Drug Discovery Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe In-Silico Drug Discovery Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe In-Silico Drug Discovery Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe In-Silico Drug Discovery Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe In-Silico Drug Discovery Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe In-Silico Drug Discovery Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific In-Silico Drug Discovery Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific In-Silico Drug Discovery Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific In-Silico Drug Discovery Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific In-Silico Drug Discovery Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific In-Silico Drug Discovery Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific In-Silico Drug Discovery Revenue by Region (2023-2028) & (USD Million)
Table 75. South America In-Silico Drug Discovery Revenue by Type (2017-2022) & (USD Million)
Table 76. South America In-Silico Drug Discovery Revenue by Type (2023-2028) & (USD Million)
Table 77. South America In-Silico Drug Discovery Revenue by Application (2017-2022) & (USD Million)
Table 78. South America In-Silico Drug Discovery Revenue by Application (2023-2028) & (USD Million)
Table 79. South America In-Silico Drug Discovery Revenue by Country (2017-2022) & (USD Million)
Table 80. South America In-Silico Drug Discovery Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa In-Silico Drug Discovery Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa In-Silico Drug Discovery Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa In-Silico Drug Discovery Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa In-Silico Drug Discovery Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa In-Silico Drug Discovery Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa In-Silico Drug Discovery Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. In-Silico Drug Discovery Picture
Figure 2. Global In-Silico Drug Discovery Revenue Market Share by Type in 2021
Figure 3. Software as a Service (Cloud)
Figure 4. Consultancy as a Service
Figure 5. Software
Figure 6. In-Silico Drug Discovery Revenue Market Share by Application in 2021
Figure 7. Contract Research Organization Picture
Figure 8. Pharmaceutical Industry Picture
Figure 9. Academic and Research Institutes Picture
Figure 10. Others Picture
Figure 11. Global In-Silico Drug Discovery Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global In-Silico Drug Discovery Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global In-Silico Drug Discovery Revenue Market Share by Region (2017-2028)
Figure 14. Global In-Silico Drug Discovery Revenue Market Share by Region in 2021
Figure 15. North America In-Silico Drug Discovery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe In-Silico Drug Discovery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific In-Silico Drug Discovery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America In-Silico Drug Discovery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa In-Silico Drug Discovery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. In-Silico Drug Discovery Market Drivers
Figure 21. In-Silico Drug Discovery Market Restraints
Figure 22. In-Silico Drug Discovery Market Trends
Figure 23. Charles River Recent Developments and Future Plans
Figure 24. Certara USA, Inc. Recent Developments and Future Plans
Figure 25. Evotec Recent Developments and Future Plans
Figure 26. Dassault System (Biovia) Recent Developments and Future Plans
Figure 27. Albany Molecular Research Inc. (AMRI) Recent Developments and Future Plans
Figure 28. Selvita Recent Developments and Future Plans
Figure 29. Schrödinger, Inc. Recent Developments and Future Plans
Figure 30. GVK BIO Recent Developments and Future Plans
Figure 31. OpenEye Scientific Software Recent Developments and Future Plans
Figure 32. Chemical Computing Group (CCG) Recent Developments and Future Plans
Figure 33. Global In-Silico Drug Discovery Revenue Share by Players in 2021
Figure 34. In-Silico Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 35. Global Top 3 Players In-Silico Drug Discovery Revenue Market Share in 2021
Figure 36. Global Top 10 Players In-Silico Drug Discovery Revenue Market Share in 2021
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 38. Global In-Silico Drug Discovery Revenue Share by Type in 2021
Figure 39. Global In-Silico Drug Discovery Market Share Forecast by Type (2023-2028)
Figure 40. Global In-Silico Drug Discovery Revenue Share by Application in 2021
Figure 41. Global In-Silico Drug Discovery Market Share Forecast by Application (2023-2028)
Figure 42. North America In-Silico Drug Discovery Sales Market Share by Type (2017-2028)
Figure 43. North America In-Silico Drug Discovery Sales Market Share by Application (2017-2028)
Figure 44. North America In-Silico Drug Discovery Revenue Market Share by Country (2017-2028)
Figure 45. United States In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe In-Silico Drug Discovery Sales Market Share by Type (2017-2028)
Figure 49. Europe In-Silico Drug Discovery Sales Market Share by Application (2017-2028)
Figure 50. Europe In-Silico Drug Discovery Revenue Market Share by Country (2017-2028)
Figure 51. Germany In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific In-Silico Drug Discovery Sales Market Share by Type (2017-2028)
Figure 57. Asia-Pacific In-Silico Drug Discovery Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific In-Silico Drug Discovery Revenue Market Share by Region (2017-2028)
Figure 59. China In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South Korea In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America In-Silico Drug Discovery Sales Market Share by Type (2017-2028)
Figure 66. South America In-Silico Drug Discovery Sales Market Share by Application (2017-2028)
Figure 67. South America In-Silico Drug Discovery Revenue Market Share by Country (2017-2028)
Figure 68. Brazil In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East and Africa In-Silico Drug Discovery Sales Market Share by Type (2017-2028)
Figure 71. Middle East and Africa In-Silico Drug Discovery Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa In-Silico Drug Discovery Revenue Market Share by Country (2017-2028)
Figure 73. Turkey In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. UAE In-Silico Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
